Join to view full profile
261 James Street, 3fMorristown, NJ 07960
Phone+1 973-998-5926
Fax+1 973-538-4957
Dr. Levine is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Orthopaedic Surgery, 1966 - 1969- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 1965 - 1966
Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1964 - 1965
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1964
Certifications & Licensure
NJ State Medical License 1966 - 2025
American Board of Orthopaedic Surgery Orthopaedic Surgery
Publications & Presentations
PubMed
- 8 citationsInvestigation of Drug Delivery by Iontophoresis in a Surgical Wound Utilizing MicrodialysisHeidi J. Holovics, Carter R. Anderson, Barry S. Levine, Ho-Wah Hui, Craig E. Lunte
Pharmaceutical Research. 2008-08-01 - 27 citationsIndole-3-carbinol, but not its major digestive product 3,3′-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450James A. Crowell, John G. Page, Barry S. Levine, Michael J. Tomlinson, Charles D. Hébert
Toxicology and Applied Pharmacology. 2006-03-01 - 244 citationsResveratrol-Associated Renal ToxicityJames A. Crowell, Peter J. Korytko, Robert L. Morrissey, Tristan D. Booth, Barry S. Levine
Toxicological Sciences. 2004-12-01
Grant Support
- Fourteen Day Oral Rangefinding Study In Rats And Dogs AnDivision Of Cancer Prevention And Control1999–2001
- Toxicological Evaluations Of Potential Medications ToNational Institute On Drug Abuse1999–2000
- Preclinical Toxicology &Pharmacology Of Drugs DevelopedDivision Of Cancer Treatment1998–2000
- Pharmacokinetic &Tissue Distribution Of C14-LycopeneDivision Of Cancer Prevention And Control1998–2000
- Preclinical Toxicology - Evaluation Of Hydrongen Ion CONDivision Of Cancer Prevention And Control1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
